Literature DB >> 18079653

Reproducibility of quantitative anterior chamber angle measurements with scheimpflug video imaging.

M E Bosem1, D Morsman, M Lusky, R N Weinreb.   

Abstract

A Scheimpflug video camera with digital image analysis was used to assess iridocorneal angles in 11 eyes with nonoccludable open angles and nine eyes with occludable narrow angles. Normal eyes had a mean angle width of 28.2 +/- 2.5 degrees and eyes with occludable narrow angles had a mean angle width of 17.5 +/- 3.2 degrees . Interobserver variability was 1.98 degrees and 1.94 degrees in open and narrow angles, respectively. Intraobserver variability was 1.81 degrees . This technique provides a method for longitudinal observation and quantitative assessment of the iridocorneal angle.

Entities:  

Year:  1992        PMID: 18079653     DOI: 10.1097/00061198-199201040-00008

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  4 in total

1.  A newly developed peripheral anterior chamber depth analysis system: principle, accuracy, and reproducibility.

Authors:  K Kashiwagi; F Kashiwagi; Y Toda; K Osada; T Tsumura; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

2.  Intra-session repeatability of iridocorneal angle measurements provided by a Scheimpflug photography-based system in healthy eyes.

Authors:  Clara Ruiz-Belda; David P Piñero; Pedro Ruiz-Fortes; Roberto Soto-Negro; Myriam Moya; Rafael J Pérez-Cambrodí; Alberto Artola
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-15       Impact factor: 3.117

3.  Non-contact tests for identifying people at risk of primary angle closure glaucoma.

Authors:  Anish Jindal; Irene Ctori; Gianni Virgili; Ersilia Lucenteforte; John G Lawrenson
Journal:  Cochrane Database Syst Rev       Date:  2020-05-28

Review 4.  Angle imaging: advances and challenges.

Authors:  Desmond T L Quek; Monisha E Nongpiur; Shamira A Perera; Tin Aung
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.